nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Weight increased—Prednisone—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Esomeprazole—Pain—Mycophenolic acid—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Esomeprazole—Constipation—Mycophenolic acid—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Esomeprazole—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Esomeprazole—Weight decreased—Prednisone—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Esomeprazole—Cough—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Esomeprazole—Dizziness—Captopril—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Esomeprazole—Depression—Prednisone—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Esomeprazole—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Esomeprazole—Urticaria—Leflunomide—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Esomeprazole—Abdominal pain—Leflunomide—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Esomeprazole—Body temperature increased—Leflunomide—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Esomeprazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Esomeprazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Esomeprazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Esomeprazole—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Esomeprazole—Breast disorder—Methotrexate—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000456	0.000456	CcSEcCtD
Esomeprazole—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000456	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Esomeprazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Esomeprazole—Insomnia—Lisinopril—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Esomeprazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Esomeprazole—Paraesthesia—Lisinopril—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Esomeprazole—Vomiting—Captopril—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Esomeprazole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Esomeprazole—Dyspnoea—Lisinopril—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Esomeprazole—Rash—Captopril—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Esomeprazole—Dermatitis—Captopril—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Esomeprazole—Somnolence—Lisinopril—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Esomeprazole—Headache—Captopril—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Esomeprazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Esomeprazole—Dyspepsia—Lisinopril—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Esomeprazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Esomeprazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Esomeprazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Esomeprazole—Asthma—Methotrexate—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Esomeprazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Esomeprazole—Decreased appetite—Lisinopril—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Esomeprazole—Fatigue—Lisinopril—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Esomeprazole—Shock—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Esomeprazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00043	CcSEcCtD
Esomeprazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Esomeprazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Esomeprazole—Pancreatitis—Methotrexate—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Esomeprazole—Pain—Lisinopril—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Esomeprazole—Constipation—Lisinopril—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Esomeprazole—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Esomeprazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Esomeprazole—Bradycardia—Prednisone—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Esomeprazole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Esomeprazole—Diarrhoea—Azathioprine—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Esomeprazole—Nausea—Captopril—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Esomeprazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Esomeprazole—Asthenia—Leflunomide—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Esomeprazole—Hallucination—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Esomeprazole—Pancytopenia—Methotrexate—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Esomeprazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Esomeprazole—Pruritus—Leflunomide—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Esomeprazole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Esomeprazole—Dysuria—Methotrexate—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Esomeprazole—Neutropenia—Methotrexate—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Esomeprazole—Dizziness—Azathioprine—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Esomeprazole—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Esomeprazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Esomeprazole—Diarrhoea—Leflunomide—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Esomeprazole—Urticaria—Lisinopril—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Esomeprazole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Esomeprazole—Body temperature increased—Lisinopril—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Esomeprazole—Abdominal pain—Lisinopril—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Esomeprazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Esomeprazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Esomeprazole—Vomiting—Azathioprine—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Esomeprazole—Eye disorder—Prednisone—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Esomeprazole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Esomeprazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00039	CcSEcCtD
Esomeprazole—Infestation NOS—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Esomeprazole—Infestation—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Esomeprazole—Rash—Azathioprine—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Esomeprazole—Dermatitis—Azathioprine—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Esomeprazole—Depression—Methotrexate—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Esomeprazole—Flushing—Prednisone—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Esomeprazole—Headache—Azathioprine—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Esomeprazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Esomeprazole—Dizziness—Leflunomide—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Esomeprazole—Renal failure—Methotrexate—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Esomeprazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Esomeprazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Esomeprazole—Stomatitis—Methotrexate—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Esomeprazole—Conjunctivitis—Methotrexate—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Esomeprazole—Immune system disorder—Prednisone—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Esomeprazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Esomeprazole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Esomeprazole—Haematuria—Methotrexate—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Esomeprazole—Vomiting—Leflunomide—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Esomeprazole—Alopecia—Prednisone—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Esomeprazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000369	0.000369	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Esomeprazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Esomeprazole—Epistaxis—Methotrexate—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Esomeprazole—Rash—Leflunomide—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Esomeprazole—Dermatitis—Leflunomide—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Esomeprazole—Mental disorder—Prednisone—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Esomeprazole—Nausea—Azathioprine—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Esomeprazole—Headache—Leflunomide—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Esomeprazole—Malnutrition—Prednisone—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Esomeprazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000363	0.000363	CcSEcCtD
Esomeprazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Esomeprazole—Asthenia—Lisinopril—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Esomeprazole—Pruritus—Lisinopril—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Esomeprazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Esomeprazole—Rash—Mycophenolic acid—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Esomeprazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Esomeprazole—Hepatitis—Methotrexate—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Esomeprazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Esomeprazole—Headache—Mycophenolic acid—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Esomeprazole—Pharyngitis—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Esomeprazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Esomeprazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Esomeprazole—Nausea—Leflunomide—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Esomeprazole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000345	0.000345	CcSEcCtD
Esomeprazole—Vision blurred—Prednisone—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Esomeprazole—Urethral disorder—Methotrexate—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Esomeprazole—Diarrhoea—Lisinopril—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Esomeprazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Esomeprazole—Visual impairment—Methotrexate—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Esomeprazole—Anaemia—Prednisone—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Esomeprazole—Agitation—Prednisone—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Esomeprazole—Angioedema—Prednisone—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Esomeprazole—Dizziness—Lisinopril—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Esomeprazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Esomeprazole—Nausea—Mycophenolic acid—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Esomeprazole—Malaise—Prednisone—systemic scleroderma	0.000328	0.000328	CcSEcCtD
Esomeprazole—Vertigo—Prednisone—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Esomeprazole—Eye disorder—Methotrexate—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Esomeprazole—Tinnitus—Methotrexate—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Esomeprazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Esomeprazole—Vomiting—Lisinopril—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Esomeprazole—Immune system disorder—Methotrexate—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Esomeprazole—Rash—Lisinopril—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Esomeprazole—Dermatitis—Lisinopril—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Esomeprazole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Esomeprazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Esomeprazole—Hypertension—Prednisone—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Esomeprazole—Chills—Methotrexate—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Esomeprazole—Headache—Lisinopril—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Esomeprazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Esomeprazole—Arthralgia—Prednisone—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Esomeprazole—Myalgia—Prednisone—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Esomeprazole—Anxiety—Prednisone—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Esomeprazole—Alopecia—Methotrexate—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Esomeprazole—Discomfort—Prednisone—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Esomeprazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Esomeprazole—Nausea—Lisinopril—systemic scleroderma	0.000297	0.000297	CcSEcCtD
Esomeprazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000297	0.000297	CcSEcCtD
Esomeprazole—Infection—Prednisone—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Esomeprazole—Shock—Prednisone—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Esomeprazole—Nervous system disorder—Prednisone—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Esomeprazole—Tachycardia—Prednisone—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Esomeprazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Esomeprazole—Skin disorder—Prednisone—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Esomeprazole—Hyperhidrosis—Prednisone—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Esomeprazole—Anorexia—Prednisone—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Esomeprazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Esomeprazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Esomeprazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Esomeprazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Esomeprazole—Insomnia—Prednisone—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Esomeprazole—Paraesthesia—Prednisone—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Esomeprazole—Cough—Methotrexate—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Esomeprazole—Dyspepsia—Prednisone—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Esomeprazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Esomeprazole—Decreased appetite—Prednisone—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Esomeprazole—Fatigue—Prednisone—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Esomeprazole—Constipation—Prednisone—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Esomeprazole—Infection—Methotrexate—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Esomeprazole—Feeling abnormal—Prednisone—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—systemic scleroderma	0.000244	0.000244	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—systemic scleroderma	0.000237	0.000237	CcSEcCtD
Esomeprazole—Urticaria—Prednisone—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Esomeprazole—Abdominal pain—Prednisone—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Esomeprazole—Body temperature increased—Prednisone—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Esomeprazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Esomeprazole—Asthenia—Prednisone—systemic scleroderma	0.000213	0.000213	CcSEcCtD
Esomeprazole—Pain—Methotrexate—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Esomeprazole—Pruritus—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Esomeprazole—Diarrhoea—Prednisone—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Esomeprazole—Dizziness—Prednisone—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Esomeprazole—Vomiting—Prednisone—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Esomeprazole—Rash—Prednisone—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Esomeprazole—Dermatitis—Prednisone—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Esomeprazole—Headache—Prednisone—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—systemic scleroderma	0.000178	0.000178	CcSEcCtD
Esomeprazole—Nausea—Prednisone—systemic scleroderma	0.000177	0.000177	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Esomeprazole—Rash—Methotrexate—systemic scleroderma	0.000157	0.000157	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Esomeprazole—Headache—Methotrexate—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—systemic scleroderma	0.000148	0.000148	CcSEcCtD
